Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
J&J's Tremfya Meets All Endpoints in Phase III UC Study, Eyes FDA Approval for SC Induction
CompanyDrug

J&J’s Tremfya Meets All Endpoints in Phase III UC Study, Eyes FDA Approval for SC Induction

February 24, 2025
MicroPort CardioFlow's AnchorMan LAA Occluder System Earns CE Mark Approval
CompanyMedical Device

MicroPort CardioFlow’s AnchorMan LAA Occluder System Earns CE Mark Approval

February 24, 2025
AIM Vaccine Leverages DeepSeek AI to Optimize mRNA Shingles Vaccine Design
CompanyDrug

AIM Vaccine Leverages DeepSeek AI to Optimize mRNA Shingles Vaccine Design

February 24, 2025
Innovent Biologics' Ipilimumab NDA Accepted by CDE with Priority Review for Colon Cancer
CompanyDrug

Innovent Biologics’ Ipilimumab NDA Accepted by CDE with Priority Review for Colon Cancer

February 24, 2025
AI in Healthcare: The Impact of DeepSeek Technology and Industry Developments
Policy / Regulatory

AI in Healthcare: The Impact of DeepSeek Technology and Industry Developments

February 23, 2025
In-Depth Analysis of the National Healthcare Security Policy: A Guide to Key Reforms and Implications
Policy / Regulatory

In-Depth Analysis of the National Healthcare Security Policy: A Guide to Key Reforms and Implications

February 22, 2025
State Council's Draft Plan Boosts Innovative Drug Development via Medical Insurance Reforms
Policy / Regulatory

State Council’s Draft Plan Boosts Innovative Drug Development via Medical Insurance Reforms

February 22, 2025
Roche Unveils Sequencing by Expansion (SBX) Technology for Next-Generation Sequencing
CompanyMedical Device

Roche Unveils Sequencing by Expansion (SBX) Technology for Next-Generation Sequencing

February 22, 2025
Shanghai Issues Legal Guidebook for Innovative Drug Marketing
Policy / Regulatory

Shanghai Issues Legal Guidebook for Innovative Drug Marketing

February 22, 2025
China Outlines Drug Pricing Reforms, Encourages Insurance Funds for Innovation
Policy / Regulatory

China Outlines Drug Pricing Reforms, Encourages Insurance Funds for Innovation

February 22, 2025
Roche's Tecentriq Wins Japan Approval for Alveolar Soft Part Sarcoma
CompanyDrug

Roche’s Tecentriq Wins Japan Approval for Alveolar Soft Part Sarcoma

February 21, 2025
GSK's Nucala Receives NMPA Review for COPD Treatment
CompanyDrug

GSK’s Nucala Receives NMPA Review for COPD Treatment

February 21, 2025
1 2 … 6 7 8 9 10 … 26 27
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up